Global Oncology Clinical Trial Supply, Demand and Key Producers, 2023-2029

Description

The global Oncology Clinical Trial market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Oncology trials are predominantly early-phase studies that evaluate surrogate end points and are small, single arm, and open label.

Clinical trials are the final step in a long process that begins with research in a lab.

This report studies the global Oncology Clinical Trial demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Oncology Clinical Trial, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Oncology Clinical Trial that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Oncology Clinical Trial total market, 2018-2029, (USD Million)
Global Oncology Clinical Trial total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Oncology Clinical Trial total market, key domestic companies and share, (USD Million)
Global Oncology Clinical Trial revenue by player and market share 2018-2023, (USD Million)
Global Oncology Clinical Trial total market by Type, CAGR, 2018-2029, (USD Million)
Global Oncology Clinical Trial total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Oncology Clinical Trial market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include IQVIA, Charles River Laboratory, ICON Plc, Medelis, Inc., Medpace Holdings, Inc., PAREXEL International, Pharmaceutical Product Development, LLC, Pivotal and PRA Health Sciences, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Oncology Clinical Trial market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Oncology Clinical Trial Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Oncology Clinical Trial Market, Segmentation by Type
    Prostate Cancer
    Lung Cancer
    Breast Cancer
    Leukemia
    Others

Global Oncology Clinical Trial Market, Segmentation by Application
    Hospital
    Clinic
    Lab

Companies Profiled:
    IQVIA
    Charles River Laboratory
    ICON Plc
    Medelis, Inc.
    Medpace Holdings, Inc.
    PAREXEL International
    Pharmaceutical Product Development, LLC
    Pivotal
    PRA Health Sciences
    Syneos Health

Key Questions Answered
1. How big is the global Oncology Clinical Trial market?
2. What is the demand of the global Oncology Clinical Trial market?
3. What is the year over year growth of the global Oncology Clinical Trial market?
4. What is the total value of the global Oncology Clinical Trial market?
5. Who are the major players in the global Oncology Clinical Trial market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Oncology Clinical Trial Introduction
    1.2 World Oncology Clinical Trial Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Oncology Clinical Trial Total Market by Region (by Headquarter Location)
        1.3.1 World Oncology Clinical Trial Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Oncology Clinical Trial Market Size (2018-2029)
        1.3.3 China Oncology Clinical Trial Market Size (2018-2029)
        1.3.4 Europe Oncology Clinical Trial Market Size (2018-2029)
        1.3.5 Japan Oncology Clinical Trial Market Size (2018-2029)
        1.3.6 South Korea Oncology Clinical Trial Market Size (2018-2029)
        1.3.7 ASEAN Oncology Clinical Trial Market Size (2018-2029)
        1.3.8 India Oncology Clinical Trial Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Oncology Clinical Trial Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Oncology Clinical Trial Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Oncology Clinical Trial Consumption Value (2018-2029)
    2.2 World Oncology Clinical Trial Consumption Value by Region
        2.2.1 World Oncology Clinical Trial Consumption Value by Region (2018-2023)
        2.2.2 World Oncology Clinical Trial Consumption Value Forecast by Region (2024-2029)
    2.3 United States Oncology Clinical Trial Consumption Value (2018-2029)
    2.4 China Oncology Clinical Trial Consumption Value (2018-2029)
    2.5 Europe Oncology Clinical Trial Consumption Value (2018-2029)
    2.6 Japan Oncology Clinical Trial Consumption Value (2018-2029)
    2.7 South Korea Oncology Clinical Trial Consumption Value (2018-2029)
    2.8 ASEAN Oncology Clinical Trial Consumption Value (2018-2029)
    2.9 India Oncology Clinical Trial Consumption Value (2018-2029)

3 World Oncology Clinical Trial Companies Competitive Analysis
    3.1 World Oncology Clinical Trial Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Oncology Clinical Trial Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Oncology Clinical Trial in 2022
        3.2.3 Global Concentration Ratios (CR8) for Oncology Clinical Trial in 2022
    3.3 Oncology Clinical Trial Company Evaluation Quadrant
    3.4 Oncology Clinical Trial Market: Overall Company Footprint Analysis
        3.4.1 Oncology Clinical Trial Market: Region Footprint
        3.4.2 Oncology Clinical Trial Market: Company Product Type Footprint
        3.4.3 Oncology Clinical Trial Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Oncology Clinical Trial Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Oncology Clinical Trial Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Oncology Clinical Trial Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Oncology Clinical Trial Consumption Value Comparison
        4.2.1 United States VS China: Oncology Clinical Trial Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Oncology Clinical Trial Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Oncology Clinical Trial Companies and Market Share, 2018-2023
        4.3.1 United States Based Oncology Clinical Trial Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Oncology Clinical Trial Revenue, (2018-2023)
    4.4 China Based Companies Oncology Clinical Trial Revenue and Market Share, 2018-2023
        4.4.1 China Based Oncology Clinical Trial Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Oncology Clinical Trial Revenue, (2018-2023)
    4.5 Rest of World Based Oncology Clinical Trial Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Oncology Clinical Trial Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Oncology Clinical Trial Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Oncology Clinical Trial Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Prostate Cancer
        5.2.2 Lung Cancer
        5.2.3 Breast Cancer
        5.2.4 Leukemia
        5.2.5 Others
    5.3 Market Segment by Type
        5.3.1 World Oncology Clinical Trial Market Size by Type (2018-2023)
        5.3.2 World Oncology Clinical Trial Market Size by Type (2024-2029)
        5.3.3 World Oncology Clinical Trial Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Oncology Clinical Trial Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Hospital
        6.2.2 Clinic
        6.2.3 Lab
    6.3 Market Segment by Application
        6.3.1 World Oncology Clinical Trial Market Size by Application (2018-2023)
        6.3.2 World Oncology Clinical Trial Market Size by Application (2024-2029)
        6.3.3 World Oncology Clinical Trial Market Size by Application (2018-2029)

7 Company Profiles
    7.1 IQVIA
        7.1.1 IQVIA Details
        7.1.2 IQVIA Major Business
        7.1.3 IQVIA Oncology Clinical Trial Product and Services
        7.1.4 IQVIA Oncology Clinical Trial Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 IQVIA Recent Developments/Updates
        7.1.6 IQVIA Competitive Strengths & Weaknesses
    7.2 Charles River Laboratory
        7.2.1 Charles River Laboratory Details
        7.2.2 Charles River Laboratory Major Business
        7.2.3 Charles River Laboratory Oncology Clinical Trial Product and Services
        7.2.4 Charles River Laboratory Oncology Clinical Trial Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 Charles River Laboratory Recent Developments/Updates
        7.2.6 Charles River Laboratory Competitive Strengths & Weaknesses
    7.3 ICON Plc
        7.3.1 ICON Plc Details
        7.3.2 ICON Plc Major Business
        7.3.3 ICON Plc Oncology Clinical Trial Product and Services
        7.3.4 ICON Plc Oncology Clinical Trial Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 ICON Plc Recent Developments/Updates
        7.3.6 ICON Plc Competitive Strengths & Weaknesses
    7.4 Medelis, Inc.
        7.4.1 Medelis, Inc. Details
        7.4.2 Medelis, Inc. Major Business
        7.4.3 Medelis, Inc. Oncology Clinical Trial Product and Services
        7.4.4 Medelis, Inc. Oncology Clinical Trial Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 Medelis, Inc. Recent Developments/Updates
        7.4.6 Medelis, Inc. Competitive Strengths & Weaknesses
    7.5 Medpace Holdings, Inc.
        7.5.1 Medpace Holdings, Inc. Details
        7.5.2 Medpace Holdings, Inc. Major Business
        7.5.3 Medpace Holdings, Inc. Oncology Clinical Trial Product and Services
        7.5.4 Medpace Holdings, Inc. Oncology Clinical Trial Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 Medpace Holdings, Inc. Recent Developments/Updates
        7.5.6 Medpace Holdings, Inc. Competitive Strengths & Weaknesses
    7.6 PAREXEL International
        7.6.1 PAREXEL International Details
        7.6.2 PAREXEL International Major Business
        7.6.3 PAREXEL International Oncology Clinical Trial Product and Services
        7.6.4 PAREXEL International Oncology Clinical Trial Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 PAREXEL International Recent Developments/Updates
        7.6.6 PAREXEL International Competitive Strengths & Weaknesses
    7.7 Pharmaceutical Product Development, LLC
        7.7.1 Pharmaceutical Product Development, LLC Details
        7.7.2 Pharmaceutical Product Development, LLC Major Business
        7.7.3 Pharmaceutical Product Development, LLC Oncology Clinical Trial Product and Services
        7.7.4 Pharmaceutical Product Development, LLC Oncology Clinical Trial Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 Pharmaceutical Product Development, LLC Recent Developments/Updates
        7.7.6 Pharmaceutical Product Development, LLC Competitive Strengths & Weaknesses
    7.8 Pivotal
        7.8.1 Pivotal Details
        7.8.2 Pivotal Major Business
        7.8.3 Pivotal Oncology Clinical Trial Product and Services
        7.8.4 Pivotal Oncology Clinical Trial Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 Pivotal Recent Developments/Updates
        7.8.6 Pivotal Competitive Strengths & Weaknesses
    7.9 PRA Health Sciences
        7.9.1 PRA Health Sciences Details
        7.9.2 PRA Health Sciences Major Business
        7.9.3 PRA Health Sciences Oncology Clinical Trial Product and Services
        7.9.4 PRA Health Sciences Oncology Clinical Trial Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 PRA Health Sciences Recent Developments/Updates
        7.9.6 PRA Health Sciences Competitive Strengths & Weaknesses
    7.10 Syneos Health
        7.10.1 Syneos Health Details
        7.10.2 Syneos Health Major Business
        7.10.3 Syneos Health Oncology Clinical Trial Product and Services
        7.10.4 Syneos Health Oncology Clinical Trial Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 Syneos Health Recent Developments/Updates
        7.10.6 Syneos Health Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Oncology Clinical Trial Industry Chain
    8.2 Oncology Clinical Trial Upstream Analysis
    8.3 Oncology Clinical Trial Midstream Analysis
    8.4 Oncology Clinical Trial Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Oncology Clinical Trial Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Oncology Clinical Trial Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Oncology Clinical Trial Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Oncology Clinical Trial Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Oncology Clinical Trial Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Oncology Clinical Trial Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Oncology Clinical Trial Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Oncology Clinical Trial Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Oncology Clinical Trial Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Oncology Clinical Trial Players in 2022
    Table 12. World Oncology Clinical Trial Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Oncology Clinical Trial Company Evaluation Quadrant
    Table 14. Head Office of Key Oncology Clinical Trial Player
    Table 15. Oncology Clinical Trial Market: Company Product Type Footprint
    Table 16. Oncology Clinical Trial Market: Company Product Application Footprint
    Table 17. Oncology Clinical Trial Mergers & Acquisitions Activity
    Table 18. United States VS China Oncology Clinical Trial Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Oncology Clinical Trial Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Oncology Clinical Trial Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Oncology Clinical Trial Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Oncology Clinical Trial Revenue Market Share (2018-2023)
    Table 23. China Based Oncology Clinical Trial Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Oncology Clinical Trial Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Oncology Clinical Trial Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Oncology Clinical Trial Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Oncology Clinical Trial Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Oncology Clinical Trial Revenue Market Share (2018-2023)
    Table 29. World Oncology Clinical Trial Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Oncology Clinical Trial Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Oncology Clinical Trial Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Oncology Clinical Trial Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World Oncology Clinical Trial Market Size by Application (2018-2023) & (USD Million)
    Table 34. World Oncology Clinical Trial Market Size by Application (2024-2029) & (USD Million)
    Table 35. IQVIA Basic Information, Area Served and Competitors
    Table 36. IQVIA Major Business
    Table 37. IQVIA Oncology Clinical Trial Product and Services
    Table 38. IQVIA Oncology Clinical Trial Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. IQVIA Recent Developments/Updates
    Table 40. IQVIA Competitive Strengths & Weaknesses
    Table 41. Charles River Laboratory Basic Information, Area Served and Competitors
    Table 42. Charles River Laboratory Major Business
    Table 43. Charles River Laboratory Oncology Clinical Trial Product and Services
    Table 44. Charles River Laboratory Oncology Clinical Trial Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. Charles River Laboratory Recent Developments/Updates
    Table 46. Charles River Laboratory Competitive Strengths & Weaknesses
    Table 47. ICON Plc Basic Information, Area Served and Competitors
    Table 48. ICON Plc Major Business
    Table 49. ICON Plc Oncology Clinical Trial Product and Services
    Table 50. ICON Plc Oncology Clinical Trial Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. ICON Plc Recent Developments/Updates
    Table 52. ICON Plc Competitive Strengths & Weaknesses
    Table 53. Medelis, Inc. Basic Information, Area Served and Competitors
    Table 54. Medelis, Inc. Major Business
    Table 55. Medelis, Inc. Oncology Clinical Trial Product and Services
    Table 56. Medelis, Inc. Oncology Clinical Trial Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. Medelis, Inc. Recent Developments/Updates
    Table 58. Medelis, Inc. Competitive Strengths & Weaknesses
    Table 59. Medpace Holdings, Inc. Basic Information, Area Served and Competitors
    Table 60. Medpace Holdings, Inc. Major Business
    Table 61. Medpace Holdings, Inc. Oncology Clinical Trial Product and Services
    Table 62. Medpace Holdings, Inc. Oncology Clinical Trial Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. Medpace Holdings, Inc. Recent Developments/Updates
    Table 64. Medpace Holdings, Inc. Competitive Strengths & Weaknesses
    Table 65. PAREXEL International Basic Information, Area Served and Competitors
    Table 66. PAREXEL International Major Business
    Table 67. PAREXEL International Oncology Clinical Trial Product and Services
    Table 68. PAREXEL International Oncology Clinical Trial Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. PAREXEL International Recent Developments/Updates
    Table 70. PAREXEL International Competitive Strengths & Weaknesses
    Table 71. Pharmaceutical Product Development, LLC Basic Information, Area Served and Competitors
    Table 72. Pharmaceutical Product Development, LLC Major Business
    Table 73. Pharmaceutical Product Development, LLC Oncology Clinical Trial Product and Services
    Table 74. Pharmaceutical Product Development, LLC Oncology Clinical Trial Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. Pharmaceutical Product Development, LLC Recent Developments/Updates
    Table 76. Pharmaceutical Product Development, LLC Competitive Strengths & Weaknesses
    Table 77. Pivotal Basic Information, Area Served and Competitors
    Table 78. Pivotal Major Business
    Table 79. Pivotal Oncology Clinical Trial Product and Services
    Table 80. Pivotal Oncology Clinical Trial Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. Pivotal Recent Developments/Updates
    Table 82. Pivotal Competitive Strengths & Weaknesses
    Table 83. PRA Health Sciences Basic Information, Area Served and Competitors
    Table 84. PRA Health Sciences Major Business
    Table 85. PRA Health Sciences Oncology Clinical Trial Product and Services
    Table 86. PRA Health Sciences Oncology Clinical Trial Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. PRA Health Sciences Recent Developments/Updates
    Table 88. Syneos Health Basic Information, Area Served and Competitors
    Table 89. Syneos Health Major Business
    Table 90. Syneos Health Oncology Clinical Trial Product and Services
    Table 91. Syneos Health Oncology Clinical Trial Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 92. Global Key Players of Oncology Clinical Trial Upstream (Raw Materials)
    Table 93. Oncology Clinical Trial Typical Customers
List of Figure
    Figure 1. Oncology Clinical Trial Picture
    Figure 2. World Oncology Clinical Trial Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Oncology Clinical Trial Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Oncology Clinical Trial Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Oncology Clinical Trial Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Oncology Clinical Trial Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Oncology Clinical Trial Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Oncology Clinical Trial Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Oncology Clinical Trial Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Oncology Clinical Trial Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Oncology Clinical Trial Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Oncology Clinical Trial Revenue (2018-2029) & (USD Million)
    Figure 13. Oncology Clinical Trial Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Oncology Clinical Trial Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Oncology Clinical Trial Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Oncology Clinical Trial Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Oncology Clinical Trial Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Oncology Clinical Trial Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Oncology Clinical Trial Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Oncology Clinical Trial Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Oncology Clinical Trial Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Oncology Clinical Trial Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Oncology Clinical Trial by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Oncology Clinical Trial Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Oncology Clinical Trial Markets in 2022
    Figure 27. United States VS China: Oncology Clinical Trial Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Oncology Clinical Trial Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Oncology Clinical Trial Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Oncology Clinical Trial Market Size Market Share by Type in 2022
    Figure 31. Prostate Cancer
    Figure 32. Lung Cancer
    Figure 33. Breast Cancer
    Figure 34. Leukemia
    Figure 35. Others
    Figure 36. World Oncology Clinical Trial Market Size Market Share by Type (2018-2029)
    Figure 37. World Oncology Clinical Trial Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 38. World Oncology Clinical Trial Market Size Market Share by Application in 2022
    Figure 39. Hospital
    Figure 40. Clinic
    Figure 41. Lab
    Figure 42. Oncology Clinical Trial Industrial Chain
    Figure 43. Methodology
    Figure 44. Research Process and Data Source